Scientific Sessions 2025  /  Innovations and Challenges in Preclinical Studies of Group 2 and Group 3 PH  /  Combined Pre- and Post-Capillary PH: What Models Do We Use to Study the Disease?
Logo

American Heart Association

  35
  0

Final ID:

Combined Pre- and Post-Capillary PH: What Models Do We Use to Study the Disease?

  • Agrawal, Vineet  ( Vanderbilt University Medical Cente , Brentwood , Tennessee , United States )
  • Brittain, Evan  ( VANDERBILT UNIVERSITY , Nashville , Tennessee , United States )
  • Maron, Brad  ( University of Maryland , Sharon , Massachusetts , United States )
    • Author Disclosures:
    Vineet Agrawal: DO NOT have relevant financial relationships | Evan Brittain: DO NOT have relevant financial relationships | Brad Maron: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Innovations and Challenges in Preclinical Studies of Group 2 and Group 3 PH

Monday, 11/10/2025 , 08:00AM - 09:15AM

Cardiovascular Seminar

More abstracts on this topic:
Finding Drugs to Repurpose for Groups 2 and 3 PH: Is There Hope?

Spiekerkoetter Edda, Toshner Mark, Prins Kurt

Heterogeneity Among Preclinical Models of Group 2 or Group 3 PH: Myth or Reality?

Lai Yen Chun, Shimoda Larissa, Goncharova Elena

More abstracts from these authors:
Myocardial Transcriptomics Differentiates Decompensated, Compensated, and Healthy Right Ventricular Samples in End Stage Heart Failure

Garry Jonah, Davogustto Giovanni, Agrawal Vineet, Brittain Evan

Pulmonary Hypertension Associated with Left Heart Disease: Clinical Presentations, Implications for the Right Ventricle, and Treatment Targets

Maron Brad, Tedford Ryan, Brittain Evan

You have to be authorized to contact abstract author. Please, Login
Not Available